 | | 代码：600276名称：恒瑞医药 |
| | | | |
| 变更时间 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-09-30 | | 变动原因 | 中报 | 季报 | 年报 | 季报 | 季报 | | 流动资产(万元) | 151,737.50 | 147,371.18 | 149,487.26 | 128,929.84 | 128,929.84 | | 固定资产(万元) | | | | | | | 总资产(万元) | 204,642.34 | 199,343.59 | 201,368.86 | 181,435.58 | 181,435.58 | | 股东权益(万元) | 178,017.89 | 170,955.86 | 163,318.07 | 147,146.59 | 147,146.59 | | 股本总额(万元) | 51,728.60 | 43,107.17 | 43,107.17 | 43,107.17 | 43,107.17 | | 流动负债(万元) | 26,545.28 | 27,901.95 | 35,500.90 | 33,941.14 | 33,941.14 | | 长期负债(万元) | | | | | | | 主营业务收入(万元) | 119,748.30 | 59,849.46 | 195,966.01 | 138,711.71 | 48,696.59 | | 主营业务利润(万元) | | | | | | | 营业利润(万元) | 25,818.35 | 10,198.62 | 50,764.28 | 33,906.28 | 15,146.88 | | 利润总额(万元) | 25,562.26 | 10,214.68 | 51,145.95 | 34,155.44 | 15,378.93 | | 净利润(万元) | 19,181.74 | 7,428.79 | 41,292.13 | 24,945.93 | 9,570.39 | 扣除非经营性
损益后净利润(万元) | | | | | | 每股经营活
动产生的现
金流量净额(元) | 0.17 | 0.14 | 0.51 | 0.70 | 0.70 | | 每股收益(元) | 0.37 | 0.17 | 0.96 | 0.58 | 0.58 | | 每股净资产(元) | 3.40 | 3.92 | 3.75 | 3.37 | 3.37 | 调整后
每股净资产(元) | | | | | | | 净资产收益率(%) | 10.91 | 4.40 | 25.56 | 17.18 | 17.18 | | 股东权益比例 | 0.87 | 0.86 | 0.81 | 0.81 | 0.81 | | 主营利润率(%) | | | | | |
|
